» Articles » PMID: 19682137

Leptin Increases Growth of Primary Ossification Centers in Fetal Mice

Overview
Journal J Anat
Date 2009 Aug 18
PMID 19682137
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The effect of peripheral leptin on fetal primary ossification centers during the early phases of bone histogenesis was investigated by administration of leptin to pregnant mice. Fourteen pregnant mice were divided into two groups. The treated pregnant group was subcutaneously injected in the intrascapular region with supraphysiologic doses (2 mg kg(-1)) of leptin (Vinci Biochem, Firenze, Italy) in a volume of 0.1 mL per 10 g body weight, at the 7th, 9th and 11th day of gestation. The control group was treated with physiological solution in the same manner and same times as the treated group. The new-born mice were killed 1 day after birth and the primary ossification centers were stained with Alizarin Red S after diaphanizing the soft tissues in 1% potassium hydroxide. The development of both endochondral and intramembranous ossification centers was morphometrically analysed in long bones. The results showed that the ossification centers of mice born by mothers treated with leptin grow more rapidly in both length and cross-sectional area compared with mice born by the untreated mothers. As the development of long bones depends on endochondral ossification occurring at proximal and distal epiphyseal plates as well as on intramembranous ossification along the periosteal surface, it appears that leptin activates the differentiation and proliferation of both chondrocytes and osteoblasts. The role of leptin as a growth factor of cartilage and bone is discussed in the light of the data reported in the literature.

Citing Articles

Concise Review: Stem/Progenitor Cell Proteoglycans Decorated with 7-D-4, 4-C-3, and 3-B-3(-) Chondroitin Sulfate Motifs Are Morphogenetic Markers of Tissue Development.

Hayes A, Smith S, Caterson B, Melrose J Stem Cells. 2018; 36(10):1475-1486.

PMID: 29893019 PMC: 6381390. DOI: 10.1002/stem.2860.


Leptin regulates disc cartilage endplate degeneration and ossification through activation of the MAPK-ERK signalling pathway in vivo and in vitro.

Han Y, Ma B, Guo S, Yang M, Li L, Wang S J Cell Mol Med. 2018; 22(4):2098-2109.

PMID: 29372627 PMC: 5867127. DOI: 10.1111/jcmm.13398.


Leptin differentially regulates chondrogenesis in mouse vertebral and tibial growth plates.

Yu B, Jiang K, Chen B, Wang H, Li X, Liu Z BMC Musculoskelet Disord. 2017; 18(1):235.

PMID: 28569158 PMC: 5452289. DOI: 10.1186/s12891-017-1601-6.


Effects of leptin on femoral fracture in rats.

Wang L, Sun S, Yang L, Lu C, Cao X J Biomed Res. 2017; 32(2):130-135.

PMID: 28550273 PMC: 5895567. DOI: 10.7555/JBR.31.20160077.


Leptin Influences Healing in the Sprague Dawley Rat Fracture Model.

Liu P, Cai M Med Sci Monit. 2017; 23:258-265.

PMID: 28088810 PMC: 5260780. DOI: 10.12659/msm.899259.


References
1.
Kishida Y, Hirao M, Tamai N, Nampei A, Fujimoto T, Nakase T . Leptin regulates chondrocyte differentiation and matrix maturation during endochondral ossification. Bone. 2005; 37(5):607-21. DOI: 10.1016/j.bone.2005.05.009. View

2.
Cornish J, Callon K, Bava U, Lin C, Naot D, Hill B . Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol. 2002; 175(2):405-15. DOI: 10.1677/joe.0.1750405. View

3.
Maor G, Rochwerger M, Segev Y, Phillip M . Leptin acts as a growth factor on the chondrocytes of skeletal growth centers. J Bone Miner Res. 2002; 17(6):1034-43. DOI: 10.1359/jbmr.2002.17.6.1034. View

4.
Thomas T, Gori F, Khosla S, Jensen M, Burguera B, Riggs B . Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology. 1999; 140(4):1630-8. DOI: 10.1210/endo.140.4.6637. View

5.
Ducy P, Amling M, Takeda S, Priemel M, Schilling A, Beil F . Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell. 2000; 100(2):197-207. DOI: 10.1016/s0092-8674(00)81558-5. View